Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
Sublingual abuse-resistant tablets comprising buprenorphine and naloxone.

No-Receipt date 2021-03953 - 13/10/2021
No-Filing date 20210402741 - 13/10/2021
No-Granting date 3108661 - 22/10/2021
No-EPO application date 15156024.0 - 18/09/2012
No-EPO granting date 2915525 - 11/08/2021
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 10/2021 - 11/11/2021
Expiration date 19/09/2032
Kind of title Validation of European Patent
Legal status VALID
Priorities US201161536180 P19/09/2011/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61P 25/36
A61P 25/30
A61P 25/04
A61K 9/20
A61K 9/00
A61K 31/485
A61K 31/4748

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1352307 OREXO AB BOX 303751 05 UPPSALA SWEDEN

Inventors
CodeFirstnameSurname
3473027 FISCHER, ANDREAS

Representatives
CodeFirstnameSurnameAddressTownZip
3463MARIAATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"KOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments

Payments history 13 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015